Hvivo plc — RNS

Regulatory news across HVO

Date	Time	Date	TitleTitle (filtered)	Source
27/08/26	07:00:00	27 Aug 2026	hVIVO acquires CRS Berlin, expanding expertise into dermatology and women's health markets	hVIVO acquires CRS Berlin, expanding expertise into dermatology and women's health markets	GNW
26/01/22	16:36:35	26 Jan 2022	Price Monitoring Extension	Price Monitoring Extension	RNS
20/01/22	07:00:08	20 Jan 2022	Malaria Human Challenge Model Launched	Malaria Human Challenge Model Launched	RNS
21/12/21	07:00:03	21 Dec 2021	£5m Influenza human challenge study contract win	£5m Influenza human challenge study contract win	RNS
16/12/21	16:41:38	16 Dec 2021	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
16/12/21	16:35:58	16 Dec 2021	Price Monitoring Extension	Price Monitoring Extension	RNS
10/12/21	11:05:34	10 Dec 2021	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
10/12/21	11:00:33	10 Dec 2021	Price Monitoring Extension	Price Monitoring Extension	RNS
10/12/21	07:05:02	10 Dec 2021	Exercise of Options	Exercise of Options	RNS
10/12/21	07:00:03	10 Dec 2021	$13.4m Influenza HCS contract win	$13.4m Influenza HCS contract win	RNS
06/12/21	07:00:09	6 Dec 2021	Positive results from Flu Human Challenge Study	Positive results from Flu Human Challenge Study	RNS
19/11/21	07:00:03	19 Nov 2021	Imutex Vaccine Phase I Study Results	Imutex Vaccine Phase I Study Results	RNS
17/11/21	07:00:05	17 Nov 2021	£5.1m RSV contract	£5.1m RSV contract	RNS
15/11/21	07:00:05	15 Nov 2021	£1.5m Contract renewal for Venn Life Sciences	£1.5m Contract renewal for Venn Life Sciences	RNS
13/10/21	07:00:09	13 Oct 2021	Directorate Change	Directorate Change	RNS
20/09/21	07:00:08	20 Sept 2021	Half-year Report	Half-year Report	RNS
20/09/21	07:00:07	20 Sept 2021	£5.7m Influenza human challenge study contract win	£5.7m Influenza human challenge study contract win	RNS
09/09/21	07:00:07	9 Sept 2021	Notice of Results	Notice of Results	RNS
07/09/21	07:00:05	7 Sept 2021	Positive results from RSV Human Challenge Study	Positive results from RSV Human Challenge Study	RNS
24/08/21	09:05:33	24 Aug 2021	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
24/08/21	09:00:37	24 Aug 2021	Price Monitoring Extension	Price Monitoring Extension	RNS
24/08/21	07:00:03	24 Aug 2021	£8.1m Asthma Human Challenge Study Contract Win	£8.1m Asthma Human Challenge Study Contract Win	RNS
09/08/21	07:00:06	9 Aug 2021	Malaria Human Challenge Model	Malaria Human Challenge Model	RNS
29/07/21	07:00:13	29 Jul 2021	DNDi Phase II trial support	DNDi Phase II trial support	RNS
22/07/21	07:00:08	22 Jul 2021	NEJM Opinion Piece	NEJM Opinion Piece	RNS
21/07/21	12:58:17	21 Jul 2021	Result of AGM	Result of AGM	RNS
14/07/21	09:06:12	14 Jul 2021	Directors’ Dealings	Directors’ Dealings	RNS
14/07/21	08:04:23	14 Jul 2021	AIM Schedule 1 update by Poolbeg Pharma plc	AIM Schedule 1 update by Poolbeg Pharma plc	RNS
14/07/21	07:01:00	14 Jul 2021	New Contract win for Open Orphan’s Breda office	New Contract win for Open Orphan’s Breda office	RNS
14/07/21	07:00:03	14 Jul 2021	COVID-19 Human Challenge Programme update	COVID-19 Human Challenge Programme update	RNS
09/07/21	07:00:03	9 Jul 2021	HRV and Flu contract	HRV and Flu contract	RNS
07/07/21	16:41:18	7 Jul 2021	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
07/07/21	16:36:05	7 Jul 2021	Price Monitoring Extension	Price Monitoring Extension	RNS
30/06/21	07:00:05	30 Jun 2021	2020 Annual Report and 2021 AGM Notice	2020 Annual Report and 2021 AGM Notice	RNS
17/06/21	07:00:09	17 Jun 2021	Final Results to 31 December 2020	Final Results to 31 December 2020	RNS
17/06/21	07:00:09	17 Jun 2021	Demerger Update	Demerger Update	RNS
14/06/21	07:00:06	14 Jun 2021	Re. Distribution in Specie and Notice of Results	Re. Distribution in Specie and Notice of Results	RNS
11/06/21	07:00:06	11 Jun 2021	Exercise of Warrants	Exercise of Warrants	RNS
19/05/21	07:00:05	19 May 2021	Court Approval	Court Approval	RNS
10/05/21	07:15:06	10 May 2021	Exercise of Share Options	Exercise of Share Options	RNS
10/05/21	07:00:06	10 May 2021	£3m COVID challenge virus manufacturing contract	£3m COVID challenge virus manufacturing contract	RNS
29/04/21	11:39:14	29 Apr 2021	Result of General Meeting	Result of General Meeting	RNS
13/04/21	07:00:05	13 Apr 2021	Potential demerger of certain non-core assets	Potential demerger of certain non-core assets	RNS
09/04/21	07:00:04	9 Apr 2021	Launch of Disease in Motion platform	Launch of Disease in Motion platform	RNS
31/03/21	07:00:06	31 Mar 2021	Holding(s) in Company	Holding(s) in Company	RNS
26/03/21	07:00:04	26 Mar 2021	£7.5m Human Challenge Study Contract	£7.5m Human Challenge Study Contract	RNS
25/03/21	07:00:08	25 Mar 2021	COVID-19 Human Challenge Programme update	COVID-19 Human Challenge Programme update	RNS
11/03/21	07:00:12	11 Mar 2021	Journal for Clinical Studies article publication	Journal for Clinical Studies article publication	RNS
09/03/21	07:00:04	9 Mar 2021	New contract win with Oxford BioTherapeutics	New contract win with Oxford BioTherapeutics	RNS
26/02/21	16:58:53	26 Feb 2021	Holding(s) in Company	Holding(s) in Company	RNS

Showing 201–250 of 589 announcements